CraniUS Plate

Brussels, Belgium, September 9, 2026 UCB announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...

Baltimore, Maryland, September 9, 2026 CraniUS Therapeutics has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...